Risky business: exploring statin eligibility across nine cardiovascular risk prediction models

3 April 2025 (08:00 - 19:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Mr Petras Navickas

Vilnius University, Vilnius (Lithuania)

6 More presentations in this session

Presentation thumbnail

Combining the systematic coronary risk evaluation (SCORE2-SCORE2-OP) with anthropometric measures to refine 10-year cardiovascular prediction in a population-based cohort study

Miss J. Lopes Oliveira (Lausanne, CH)

Abstract Slides

Presentation thumbnail

Assessment of CV risk by SCORE2 with an online calculator estimates CV risk better compared to 2-dimensional risk charts

Doctor S. Hageman (Utrecht, NL)

Abstract Slides

Presentation thumbnail

Risk stratification in chronic coronary syndrome: real-world application of SMART and EUROASPIRE scores for treatment optimization

Assistant Professor M. German-Sallo (Targu Mures, RO)

Abstract Slides

Presentation thumbnail

Validation of the European SCORE2 algorithm in four European and non-European cohort studies with contrasting populations

Doctor K. Maung (Lausanne, CH)

Abstract Slides

Presentation thumbnail

Validation of cardiovascular disease risk prediction models using population-wide electronic health records for England post COVID-19 pandemic: the SCORE2 family-of-models

Miss C. Petitjean (Cambridge, GB)

Abstract Slides

Access the full session

Session thumbnail

Estimating cardiovascular risk: does one score fit all?

The Event

Event poster

ESC Preventive Cardiology 2025

3 April - 5 April 2025

You may be interested in

Webinar

Risk assessment and lipid management in primary prevention

Congress Presentation

Cardiovascular prevention in older adults

Congress Presentation

Making personalised prevention everyone's business

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources